TY  - JOUR

T1  - Treating active rheumatoid arthritis with Janus kinase inhibitors

JO  - Lancet

UR  - http://eprints.whiterose.ac.uk/118272/

PY  - 2017/06/16

AU  - Scott DL

AU  - Stevenson MD

ED  - 

DO  - DOI: 10.1016/S0140-6736(17)31659-8

Y2  - 2024/10/18

ER  -